跳至主要内容
临床试验/NCT05051163
NCT05051163Unknown2 期

A Randomized Trial to Investigate Strategies to Reduce Mortality Among HIV-infected and HIV-exposed Children Admitted With Severe Acute Malnutrition in Mulago Hospital, Kampala, Uganda

Makerere University1 个研究点 分布在 1 个国家目标入组 300 人开始时间: 2021年6月14日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
2 期
入组人数
300
试验地点
1
主要终点
In hospital mortality

研究概览

简要总结

This study to investigate whether empiric use of an antibiotic with greater antimicrobial sensitivity (ceftriaxone) than standard-of-care (ampicillin plus gentamicin) will reduce mortality among HIV-infected/HEU children admitted to Mwanamugimu Nutrition Unit, Mulago Hospital, Kampala, Uganda.

详细描述

Background

HIV-infected and HIV-exposed-uninfected children (HEU) are at increased risk of developing malnutrition. Severely malnourished children have high mortality rates, but mortality is higher in those that are HIV-infected. Preliminary audits at the Mwanamugimu Nutrition Unit, Mulago Hospital, in 2014 showed that 43% of the severely malnourished children that died were HIV-infected/HEU, despite only 30% of admissions being HIV-infected/HEU, with deaths due to infections in 90% of cases.

Objectives

This study aims to investigate whether empiric use of an antibiotic with greater antimicrobial sensitivity (ceftriaxone) than standard-of-care (ampicillin plus gentamicin) will reduce mortality among HIV-infected/HEU children admitted to Mwanamugimu Nutrition Unit. Secondary objectives include: comparing length of hospitalization, weight-for-height, weight-for-age and height-for-age z-scores between ceftriaxone versus standard of care (ampicillin and gentamicin) treatment arms; ascertaining the pattern/antimicrobial sensitivity of pathogens among participants; determining the prevalence and factors associated with HIV-infection among severely malnourished children; and evaluating the pharmacokinetics (PK) of lopinavir/ritonavir (LPV/r) among severely malnourished HIV-infected children.

Methods

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
1 Month 至 59 Months(Child)
性别
All
接受健康志愿者

入选标准

  • HIV-infected children aged 1 to 59 months admitted at Mwanamugimu Nutrition Unit with severe acute malnutrition
  • HIV exposed but uninfected children aged 1 to 59 months admitted at Mwanamugimu Nutrition Unit with severe acute malnutrition
  • For prevalence of HIV-infection sub-study, children presenting with severe acute malnutrition on admission at Mwanamugimu Nutrition Unit.
  • For PK sub-study, the child should have been on antiretroviral therapy for at least 2weeks and should have been in hospital for at least 2weeks.

排除标准

  • For PK sub-study; a child with documented poor adherence to antiretroviral therapy.
  • For PK sub-study; a child known to have vomited the drug on the sampling day.

研究组 & 干预措施

Ceftriaxone

Experimental

Ceftriaxone will be administered intravenously at a dose of 50 - 75mg/kg once daily

干预措施: Ceftriaxone Sodium (Drug)

Ampicillin and Gentamicin

Active Comparator
  1. Ampicillin will be administered intravenously at a dose of 50mg/kg 6hourly
  2. Gentamicin will be administered intravenously at a dose 5mg/kg once daily

干预措施: Ampicillin (Drug)

Ampicillin and Gentamicin

Active Comparator
  1. Ampicillin will be administered intravenously at a dose of 50mg/kg 6hourly
  2. Gentamicin will be administered intravenously at a dose 5mg/kg once daily

干预措施: Gentamicin (Drug)

结局指标

主要结局

In hospital mortality

时间窗: 4 weeks

Cumulative incidence

次要结局

  • Weight-for-age z-score(90 days)
  • Length of hospitalization(90 days)
  • Weight-for-height z-score(90 days)
  • Height-for-age z-score(90 days)
  • Area under the curve (AUC 0- 12h)(12hours)
  • Pattern and antimicrobial sensitivity of pathogens(7 days)
  • HIV infection(Baseline)
  • Maximum concentration (Cmax)(12hours)
  • Concentration at 12hours post dose (C12h)(12hours)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

College of Health Sciences

Associate Professor

Makerere University

研究点 (1)

Loading locations...

相似试验

Strategies to Reduce Mortality Among HIV-infected... | 临床试验